Paragon Care Ltd (ASX: PGC) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Paragon Care Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$835.93 million
P/E Ratio
48.89
Dividend Yield
1.36%
Shares Outstanding
1.66 billion
Earnings per share
0.009
Dividend per share
0.01
Year To Date Return
88.89%
Earnings Yield
2.05%
Franking
100%
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Paragon Care Ltd (ASX: PGC)
Latest News
⏸️ Investing
3 growth shares I'm thinking about buying
⏸️ Investing
3 dividend stocks I'd want in my portfolio
⏸️ Investing
Paragon Care Ltd to acquire a surgical medical device company
⏸️ Investing
ALL ORDINARIES finishes higher Thursday: 9 shares you missed
⏸️ Investing
Here's why Paragon Care Ltd reported its NPAT was down 24%
⏸️ Investing
Paragon Care Ltd announces equity raising for acquisitions
⏸️ Investing
This is how dividend-hungry investors can survive the onslaught of higher interest rates
⏸️ Investing
Paragon Care Ltd acquires medical distributor business
⏸️ Investing
3 cheap shares to buy today
⏸️ Investing
This healthcare stock is set for a nice earnings upgrade in 2018
⏸️ Investing
Why CSL Limited looks like a buy at this share price
⏸️ Investing
3 exciting small cap healthcare shares on my watchlist
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 18 Sep 2023 | $0.0060 | 100.00% | Final | 06 Oct 2023 |
| 14 Mar 2023 | $0.0060 | 100.00% | Interim | 05 Apr 2023 |
| 12 Sep 2022 | $0.0060 | 100.00% | Final | 04 Oct 2022 |
| 21 Mar 2022 | $0.0060 | 100.00% | Interim | 26 Apr 2022 |
| 13 Sep 2021 | $0.0100 | 100.00% | Final | 01 Oct 2021 |
| 21 Mar 2019 | $0.0110 | 100.00% | Interim | 26 Apr 2019 |
| 14 Sep 2018 | $0.0200 | 100.00% | Final | 12 Oct 2018 |
| 15 Mar 2018 | $0.0110 | 100.00% | Interim | 12 Apr 2018 |
| 07 Sep 2017 | $0.0000 | 100.00% | Final | 06 Oct 2017 |
| 09 Mar 2017 | $0.0110 | 100.00% | Interim | 06 Apr 2017 |
| 15 Sep 2016 | $0.0140 | 100.00% | Final | 06 Oct 2016 |
| 09 Mar 2016 | $0.0080 | 100.00% | Interim | 06 Apr 2016 |
| 08 Oct 2014 | $0.0075 | 100.00% | Final | 31 Oct 2014 |
| 07 Mar 2014 | $0.0050 | 100.00% | Interim | 31 Mar 2014 |
| 04 Oct 2013 | $0.0100 | 100.00% | Final | 31 Oct 2013 |
PGC ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Paragon Care Ltd
Paragon Care Ltd. engages in supplying medical equipment to the health and aged care markets. Its product categories include balance and mobility, beds, mattresses and furniture, carts and trolleys, consulting room equipment, dermatology and cosmetic medicine, general medical products, consumables, infection control, lighting, materials management, newborn care, operating theatre, and ophthalmic. The company was founded in 1994 and is headquartered in South Melbourne, Australia.
PGC Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 22 Nov 2024 | $0.51 | $0.01 | 2.00% | 4,859,041 | $0.50 | $0.52 | $0.49 |
| 21 Nov 2024 | $0.50 | $0.05 | 11.11% | 3,415,769 | $0.45 | $0.50 | $0.45 |
| 20 Nov 2024 | $0.45 | $-0.01 | -2.17% | 131,791 | $0.47 | $0.47 | $0.45 |
| 19 Nov 2024 | $0.46 | $0.01 | 2.20% | 546,585 | $0.47 | $0.47 | $0.46 |
| 18 Nov 2024 | $0.46 | $-0.02 | -4.26% | 273,886 | $0.47 | $0.47 | $0.46 |
| 15 Nov 2024 | $0.47 | $-0.01 | -2.08% | 218,035 | $0.48 | $0.48 | $0.46 |
| 14 Nov 2024 | $0.48 | $0.01 | 2.13% | 623,779 | $0.47 | $0.48 | $0.47 |
| 13 Nov 2024 | $0.47 | $0.01 | 2.17% | 228,838 | $0.47 | $0.47 | $0.46 |
| 12 Nov 2024 | $0.46 | $0.00 | 0.00% | 807,359 | $0.46 | $0.47 | $0.45 |
| 11 Nov 2024 | $0.46 | $-0.01 | -2.15% | 388,429 | $0.45 | $0.47 | $0.45 |
| 08 Nov 2024 | $0.47 | $-0.02 | -4.17% | 1,767,833 | $0.45 | $0.48 | $0.45 |
| 07 Nov 2024 | $0.48 | $0.06 | 14.29% | 3,552,998 | $0.43 | $0.49 | $0.42 |
| 06 Nov 2024 | $0.42 | $0.01 | 2.41% | 96,941 | $0.42 | $0.43 | $0.41 |
| 05 Nov 2024 | $0.42 | $-0.01 | -2.38% | 267,424 | $0.42 | $0.43 | $0.41 |
| 04 Nov 2024 | $0.42 | $0.01 | 2.41% | 347,035 | $0.41 | $0.43 | $0.40 |
| 01 Nov 2024 | $0.42 | $-0.01 | -2.38% | 122,046 | $0.43 | $0.44 | $0.42 |
| 31 Oct 2024 | $0.42 | $-0.03 | -6.74% | 246,680 | $0.45 | $0.45 | $0.42 |
| 30 Oct 2024 | $0.45 | $0.01 | 2.30% | 2,608,360 | $0.43 | $0.46 | $0.43 |
| 29 Oct 2024 | $0.44 | $0.00 | 0.00% | 473,664 | $0.43 | $0.44 | $0.43 |
| 28 Oct 2024 | $0.44 | $-0.01 | -2.25% | 308,438 | $0.44 | $0.45 | $0.43 |
| 25 Oct 2024 | $0.45 | $0.00 | 0.00% | 300,621 | $0.44 | $0.45 | $0.44 |
| 24 Oct 2024 | $0.45 | $0.01 | 2.30% | 253,481 | $0.44 | $0.45 | $0.44 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 03 Jun 2024 | John Walstab | Issued | 28,594,409 | $11,151,819 |
Issue of securities. As per announcement on 05-06-2024
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Philip (Phil) Nicholl | Executive Director | Nov 2019 |
Mr Nicholl is currently the CEO of one of Paragon's businesses, a company in the orthopaedics market in Australia and New Zealand. Mr Nicholl has experience in the medical devices industry having occupied senior executive roles for the companies including Stryker and Cochlear.
|
| Mr Peter Andre Lacaze | Non-Executive ChairmanNon-Executive Director | Jun 2024 |
Mr Lacaze has been involved in CH2 Holdings since 2006 as a minority shareholder and was the Chief Executive Officer between 2006 to 2008. Peter became the Chairman of CH2 Holdings in December 2015 when David Collins and Peter acquired 100% of CH2 Holdings. As an experienced Australian business leader, Peter has worked in a number of industries with particular emphasis on healthcare and travel. Peter brings a dynamic and practical approach with a long-term lens on driving business performance. He is member of Risk Committee.
|
| Mr Alan Timothy McCarthy | Non-Executive Director | Feb 2022 |
Mr McCarthy experience spans public health and private health services across Asia Pacific for more than 32 years, including CEO at Alpenglow Australia, and SRG NZ, MD of Philips ANZ, Vice-President Asia Pacific at CareFusion, Country Manager ANZ at Cardinal Health, and GM of Diagnostic Imaging at Mayne Health/Health Care of Australia. He is member of Risk Committee.
|
| Ms Carmen Rose Riley | Non-Executive Director | Jun 2024 |
Ms Riley was appointed Chief Operating Officer in 2017 after transitioning from General Manager of Sales. Before joining CH2 Holdings Carmen was CEO of PQ Lifestyles (Intouch) from July 2008, which was successfully acquired by CH2 Holdings in 2010. Prior to joining the Healthcare industry Carmen had a career within FMCG, including Supply Chain and Operations, Finance and Project Management. Carmen's experience provides strong financial and operational management skills gained from both private and ASX listed companies. She is Chair pf Risk Committee.
|
| Mr David Keith Collins | Chief Executive OfficerManaging Director | Jun 2024 |
Mr Collins was appointed as CEO and Managing Director in December 2015 of CH2 Holdings when David and Peter Lacaze acquired 100% of CH2 Holdings. David has been with CH2 Holdings since 2005 starting as Chief Financial Officer and then moving into the Managing Director role in 2008 until 2014. In 2006 David became a minority shareholder of CH2 Holdings. David spent 14 months as the Chief Financial Officer at Greencross Health Limited in Auckland. David brings experience and knowledge of the Australian and New Zealand healthcare wholesale and distribution sectors.
|
| Ms Melanie Jaye Leydin | Company Secretary | Jun 2018 |
-
|
| Melanie Jaye Leydin | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Cherie Maria Millar & David Keith Collins <Collins Millar Family> | 471,762,036 | 28.50% |
| Peter Andre Lacaze & Dianne Maree Lacaze <Lacaze Family> | 471,762,036 | 28.50% |
| Mr John Walstab(i) | 157,956,314 | 9.54% |
| Citicorp Nominees Pty Limited | 83,356,419 | 5.04% |
| HSBC Custody Nominees (Australia) Limited | 72,799,499 | 4.40% |
| BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> | 46,875,287 | 2.83% |
| First Samuel Ltd ACN 086243567 <ANF ITS MDA Clients A/C> | 20,145,625 | 1.22% |
| J P Morgan Nominees Australia Pty Limited | 12,992,454 | 0.78% |
| Certane CT Pty Ltd <Hayborough OPP Fund> | 11,000,000 | 0.66% |
| Phillip Graham Sidney Pty Ltd <Sidney Super Fund A/C> | 8,602,020 | 0.52% |
| Realm Group Pty Limited | 7,520,575 | 0.45% |
| BNP Paribas Noms Pty Ltd | 5,620,955 | 0.34% |
| Negroni Holdings Pty Ltd <The DFN A/C> | 4,727,531 | 0.29% |
| BNP Paribas Nominees Pty Ltd <HUB24 Custodial Serv Ltd> | 4,637,414 | 0.28% |
| Dixson Trust Pty Limited | 4,506,994 | 0.27% |
| Mrs Sandra Joan McDonald & Mr Andrew McDonald <McDonald Family S/Fund A/C> | 4,502,524 | 0.27% |
| JMT Investment Group VIC Pty Ltd <John Turner Super Fund A/C> | 4,500,000 | 0.27% |
| Rathvale Pty Limited | 4,152,250 | 0.25% |
| JMT Investment Group VIC Pty Ltd | 4,000,000 | 0.24% |
| Mr Richard Albarran | 3,942,129 | 0.24% |
| Mr Drew Townsend | 3,942,128 | 0.24% |
